Author

Si-Yang Li

Johns Hopkins University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 2 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Eric L. NuermbergeriD· 2 shared Andrew OweniD· 1 shared Dalin RifatiD· 1 shared Ghader Bashiri· 1 shared Henry E. PertineziD· 1 shared J. HobsoniD· 1 shared James Sacchettini· 1 shared Jean-Philippe Lanoix· 1 shared

Activity by Year

2018-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Eric L. NuermbergerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

One-Dose Efficacy of Long-Acting Sorfequiline in a Mouse Model of Tuberculosis Preventive Therapy

Si-Yang Li, J. Hobson, Nicole C. Ammerman, Henry E. Pertinez, Joanne Sharp, Nader Fotouhi, Steve P. Rannard, Andrew Owen, Eric L. Nuermberger

This study evaluates the efficacy of a single dose of long-acting sorfequiline in a mouse model for tuberculosis preventive therapy.

bioRxiv · Sep 24, 2026 · PreprintMicrobiology

Mutations in Rv2983 as a novel determinant of resistance to nitroimidazole drugs in Mycobacterium tuberculosis

Dalin Rifat, Si-Yang Li, Thomas Ioerger, Jean-Philippe Lanoix, Jin Lee, Ghader Bashiri, James Sacchettini, Eric Nuermberger

This paper identifies Rv2983 as a novel gene conferring resistance to nitroimidazole drugs in Mycobacterium tuberculosis and highlights the challenges in detecting such resistance.

bioRxiv · Oct 31, 2018 · PreprintMicrobiology